Black Rock Inc. Axsome Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,195,490 shares of AXSM stock, worth $257 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,195,490

Previous 3,239,746 1.37%

Holding current value

$257 Million

Previous $258 Million 1.11%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$69.39 - $97.64 $3.07 Million - $4.32 Million	-44,256 Reduced 1.37%	3,195,490 $255 Million
Q4 2023 Feb 13, 2024	BUY	$57.42 - $83.61 $17.5 Million - $25.5 Million	305,256 Added 10.4%	3,239,746 $258 Million
Q3 2023 Nov 13, 2023	BUY	$69.25 - $82.21 $14.6 Million - $17.3 Million	210,947 Added 7.75%	2,934,490 $205 Million
Q2 2023 Aug 11, 2023	BUY	$58.41 - $90.35 $14.9 Million - $23.1 Million	255,319 Added 10.34%	2,723,543 $196 Million
Q1 2023 May 12, 2023	SELL	$58.39 - $75.0 $2.03 Million - $2.61 Million	-34,753 Reduced 1.39%	2,468,224 $152 Million

Q4 2022 Feb 13, 2023	BUY	$39.94 - $79.72 $12.4 Million - $24.8 Million	310,722 Added 14.17%	2,502,977 $193 Million
Q3 2022 Nov 14, 2022	SELL	$36.06 - $69.85 $1.33 Million - $2.57 Million	-36,822 Reduced 1.65%	2,192,255 $97.8 Million
Q2 2022 Aug 12, 2022	BUY	$21.74 - $46.75 $2.97 Million - $6.4 Million	136,820 Added 6.54%	2,229,077 $85.4 Million
Q1 2022 May 12, 2022	SELL	$23.7 - $41.39 $411,550 - $718,737	-17,365 Reduced 0.82%	2,092,257 $86.6 Million
Q4 2021 Feb 10, 2022	BUY	$30.7 - $43.36 $1.28 Million - $1.8 Million	41,559 Added 2.01%	2,109,622 $79.7 Million
Q3 2021 Nov 09, 2021	SELL	$19.91 - $68.26 $1.05 Million - $3.6 Million	-52,691 Reduced 2.48%	2,068,063 $68.2 Million
Q2 2021 Aug 11, 2021	BUY	$50.63 - $73.5 $107 Million - $156 Million	2,120,754 New	2,120,754 $143 Million

Others Institutions Holding AXSM

# of Institutions

290

Shares Held

37.1M

Call Options Held

401K

Put Options Held

464K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.45B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account